We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.7B
AUM Growth
+$505M
(+23%)
Cap. Flow
+$389M
Cap. Flow
% of AUM
14.43%
Top 10 Holdings %
Top 10 Hldgs %
30%
Holding
764
New
141
Increased
236
Reduced
169
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$45.3M |
| 2 |
Microsoft
MSFT
|
+$40.8M |
| 3 |
Amazon
AMZN
|
+$13.8M |
| 4 |
Visa
V
|
+$13M |
| 5 |
XYZ
Block Inc
XYZ
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kimberly-Clark
KMB
|
+$5.83M |
| 2 |
Quest Diagnostics
DGX
|
+$4.67M |
| 3 |
Intellia Therapeutics
NTLA
|
+$4.01M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$3.87M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$3.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 8.5% |
| 3 | Financials | 7.19% |
| 4 | Consumer Discretionary | 5.47% |
| 5 | Communication Services | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amgen
AMGN
$201B
| $3.28M | 0.12% |
13,189
-1,100
| -8% | -$262K |
|
152
AbbVie
ABBV
$454B
| $3.23M | 0.12% |
29,878
+23,715
| +385% | +$2.54M |
|
153
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.5B
| $3.1M | 0.11% |
78,489
-2,679
| -3% | -$101K |
|
154
iShares Russell 2000 ETF
IWM
$81.2B
| $3.02M | 0.11% |
13,679
+777
| +6% | +$170K |
|
155
Thermo Fisher Scientific
TMO
$213B
| $2.97M | 0.11% |
6,499
+5,552
| +586% | +$2.65M |
|
156
Uber
UBER
$140B
| $2.94M | 0.11% |
53,931
+31,602
| +142% | +$1.76M |
|
157
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.29B
| $2.92M | 0.11% |
112,381
+366
| +0.3% | +$9.54K |
|
158
Humana
HUM
$47.4B
| $2.87M | 0.11% |
6,833
-171
| -2% | -$68.3K |
|
159
Bright Horizons
BFAM
$3.91B
| $2.82M | 0.1% |
+16,439
| New | +$2.71M |
|
|
HARP
160
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.74M | 0.1% |
13,078
-718
| -5% | -$144K |
|
161
iShares GNMA Bond ETF
GNMA
$422M
| $2.73M | 0.1% |
54,358
-5,604
| -9% | -$284K |
|
162
Huntington Ingalls Industries
HII
$11.3B
| $2.7M | 0.1% |
13,096
-271
| -2% | -$48.5K |
|
163
Walmart Inc
WMT
$863B
| $2.69M | 0.1% |
59,385
+40,842
| +220% | +$1.89M |
|
164
Skyworks Solutions
SWKS
$9.1B
| $2.64M | 0.1% |
14,400
-1,610
| -10% | -$280K |
|
165
Ball Corp
BALL
$16.6B
| $2.64M | 0.1% |
31,156
-2,236
| -7% | -$196K |
|
166
Invesco S&P 500 Equal Weight ETF
RSP
$95.3B
| $2.63M | 0.1% |
18,598
+322
| +2% | +$43.4K |
|
167
American Tower
AMT
$76.7B
| $2.62M | 0.1% |
10,963
+9,236
| +535% | +$2.06M |
|
168
Caterpillar
CAT
$412B
| $2.62M | 0.1% |
11,296
+2,751
| +32% | +$570K |
|
169
Nice
NICE
$5.09B
| $2.62M | 0.1% |
11,999
-6,000
| -33% | -$1.5M |
|
170
Chevron
CVX
$387B
| $2.61M | 0.1% |
24,947
+13,277
| +114% | +$1.3M |
|
171
Northrop Grumman
NOC
$75.8B
| $2.6M | 0.1% |
8,045
+290
| +4% | +$87.4K |
|
172
Schwab Emerging Markets Equity ETF
SCHE
$12.4B
| $2.6M | 0.1% |
81,953
-6,016
| -7% | -$196K |
|
173
Maravai LifeSciences
MRVI
$1.04B
| $2.6M | 0.1% |
+72,938
| New | +$2.42M |
|
174
Alibaba
BABA
$273B
| $2.56M | 0.09% |
11,289
+1,107
| +11% | +$272K |
|
175
Citigroup
C
$221B
| $2.49M | 0.09% |
34,272
+9,075
| +36% | +$606K |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q1 2021 Portfolio in Review
As of Q1 2021, Bailard held 764 positions worth $2.7B, up 23% from $2.19B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bailard deployed $389M of net new capital in Q1 2021, opening 141 new positions and adding to 236 existing holdings. Its largest new stake was Block Inc: 53,797 shares worth $12.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Kimberly-Clark, an estimated $5.83M trimmed.
- Bailard's largest Q1 2021 buy was Block Inc: 53,797 shares worth $12.2M.
- Bailard added most to Apple in Q1 2021, an estimated $45.3M increase.
- Bailard's biggest Q1 2021 reduction was Kimberly-Clark, cutting an estimated $5.83M.
- Bailard fully exited Barrick Mining in Q1 2021, selling an estimated $2.44M.
- Bailard's ten largest holdings make up 30% of its $2.7B portfolio in Q1 2021.
- Bailard opened 141 new positions and closed 77 in Q1 2021.
- Bailard's portfolio value rose 23% quarter-over-quarter to $2.7B.
Based on Bailard's 13F filing for Q1 2021, filed 13 May 2021.